Matteo Lambertini
Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova

Last Updated On 12/10/2025 7:34:03 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
Company: Roche
Recipient: You
Company: Lilly
Recipient: You
Company: Novartis
Recipient: You
Company: Pfizer
Recipient: You
Company: AstraZeneca
Recipient: You
Company: Takeda
Recipient: You
Company: Ipsen
Recipient: You
Company: Sandoz
Recipient: You
Company: Libbs
Recipient: You
Company: Daiichi Sankyo
Recipient: You
Company: Gilead Sciences
Recipient: You
Company: Menarini
Recipient: You

Consulting or Advisory Role
Company: Roche
Recipient: You
Company: Novartis
Recipient: You
Company: Lilly
Recipient: You
Company: AstraZeneca
Recipient: You
Company: Pfizer
Recipient: You
Company: MSD
Recipient: You
Company: Exact Sciences
Recipient: You
Company: Gilead Sciences
Recipient: You
Company: Seagen
Recipient: You
Company: Pierre Fabre
Recipient: You
Company: Menarini
Recipient: You
Company: Nordic Pharma
Recipient: You
Company: Bayer
Recipient: You
Company: Ipsen
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Gilead Sciences
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
Company: Gilead Sciences
Recipient: You
Company: Daiichi Sankyo Europe GmbH
Recipient: You
Company: Roche
Recipient: You

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
No Relationships to Disclose